Kommentar zu „Schleimpfropfen erhöhen Mortalität bei COPD“

• Literatur

• 1 Diaz AA, Orejas JL, Grumley S. et al. Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease. JAMA 2023; 329: 1832-1839
• 2 Dunican EM, Elicker BM, Henry T. et al. Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers. Am J Respir Crit Care Med 2021; 203: 957-968
• 3 Fortis S, Shannon ZK, Garcia CJ. et al. Association of Nonobstructive Chronic Bronchitis With All-Cause Mortality: A Systematic Literature Review and Meta-analysis. Chest 2022; 162: 92-100
• 4 Rennard SI, Calverley PM, Goehring UM. et al. Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD. Respir Res 2011; 12: 18
• 5 Bhatt SP, Rabe KF, Hanania NA. et al. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts. N Engl J Med 2023;